Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 14
Original Research
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,009 | Dovepress* | 3,647+ | 173 | 3,820 | |
| PubMed Central* | 362 | 185 | 547 | ||
| Totals | 4,009 | 358 | 4,367 | ||
| *Since 9 December 2022 | |||||
View citations on PubMed Central and Google Scholar